Document is current
Any future updates will be listed below
-
Authors
Osawa, Itsuki
Goto, Tadahiro
Kudo, Daisuke
Hayakawa, Mineji
Yamakawa, Kazuma
Kushimoto, Shigeki
Foster, Debra M.
Kellum, John A.
Doi, Kent
- License Information
-
More Information
Article History
Received: 30 March 2023
Accepted: 15 June 2023
First Online: 21 June 2023
Declarations
:
: JAK and DMF are employees of Spectral Medical (Toronto, Canada). KD received a speaker’s honorarium for lectures from Toray Industries, Inc. (Tokyo, Japan). No other disclosures were reported.
: The study protocol entitled "Targeted therapy using Polymyxin B hemadsorption in patients with sepsis" was approved by the Institutional Review Board of the University of Tokyo Hospital (No. 2022332NI) on February 27, 2023. This study was a secondary data analysis of de-identified data, and therefore, the requirement for informed consent was waived.
: Not applicable.
: Financial competing interests: JK and DF are employees of Spectral Medical (Toronto, Canada). KD received a speaker’s honorarium for lectures from Toray Industries, Inc. (Tokyo, Japan). No other disclosures were reported. Nonfinancial competing interests: DK and SK are institutional investigators in a clinical trial sponsored by Toray Industries, Inc. (Tokyo, Japan), but receive no payment. No other disclosures were reported.
